Comprehensive profiling of humoral immune responses to pan-respiratory pathogens: Insights from diverse cohorts.

Comprehensive profiling of humoral immune responses to pan-respiratory pathogens: Insights from diverse cohorts.

Publication date: Aug 21, 2026

The COVID-19 pandemic profoundly disrupted respiratory pathogen circulation and reshaped population-level humoral immunity. Using a high-throughput pan-respiratory pathogen protein microarray containing 56 antigens, we profiled serum immunoglobulin G (IgG) responses in 287 individuals across pre-pandemic, COVID-19, and post-pandemic periods, as well as validated the findings in an independent cohort of 175 participants. SARS-CoV-2 exposure induced strong cross-reactivity with SARS-CoV but minimal reactivity to MERS-CoV, while variant-specific immunity progressively shifted from pre-Omicron strains toward Omicron lineages. Spike-specific IgG declined over time, whereas nucleocapsid-specific IgG remained relatively stable. Immune responses to common respiratory pathogens were also broadly reorganized, with decreases in human coronaviruses, influenza B, respiratory syncytial viruses, and human parainfluenza viruses, stable influenza A responses, and increased human metapneumovirus-specific IgG. These findings define a post-pandemic humoral immune landscape and support sustained serological surveillance to identify immunity gaps, anticipate changing infection susceptibility, and strengthen preparedness for future respiratory epidemics.

Open Access PDF

Concepts Keywords
Coronaviruses Humoral immunity
Covid IgG reactivity
Immunoglobulin Post-pandemic era
Pandemic Protein microarray
Stable Respiratory pathogens

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease MESH strains
disease MESH influenza
disease MESH parainfluenza
pathway KEGG Influenza A
disease MESH infection
disease MESH Infectious Diseases
disease MESH respiratory infections
disease MESH respiratory diseases
disease MESH tar
disease MESH PRP
disease MESH included
disease MESH CVs
drug DRUGBANK Proline
disease MESH IVA
drug DRUGBANK Methylergometrine
pathway REACTOME Immune System
drug DRUGBANK Trestolone
disease MESH NPs
disease MESH mul
pathway KEGG Viral replication
disease MESH fac
disease MESH inflammation
disease MESH recurrent infection
disease MESH asymptomatic infections
drug DRUGBANK L-Valine
disease MESH coinfections
drug DRUGBANK Fenamole
disease MESH Plan
disease MESH Dis
disease MESH pneumonia
drug DRUGBANK (S)-Des-Me-Ampa
drug DRUGBANK Guanosine
disease MESH Respiratory Syncytial Virus Infection
drug DRUGBANK Carboxyamidotriazole
pathway REACTOME Influenza Infection
disease MESH Park
disease MESH Viral Infections
disease MESH Emergency
drug DRUGBANK Immune Globulin Human
drug DRUGBANK Human Serum Albumin
disease MESH PBS

Original Article

(Visited 4 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *